On February 7, in the fully enclosed workshop of Guizhou Hanfang Pharmaceutical Co., Ltd., located in Shawen Park, Guiyang High-tech Zone, bottles of medicine were filled, packaged, coded and ...... on the production line
Here, you only need to log in to the production management system, enter the name of the production raw materials, batch number, inventory quantity, ** business, warehousing time and other information closely related to production, and the production line will realize automatic feeding, quantitative solvent addition, liquid control, etc.
Hanfang Pharmaceutical Co., Ltd. is a high-tech enterprise integrating R&D, production and sales of modern Chinese patent medicines. Since 2015, the company has explored the construction of big data + intelligent manufacturing production base, introduced a number of fully automatic production lines, and built an enterprise big data platform integrating intelligent production, automatic equipment control, and automatic data collection and analysis.
In the past, the production was very tiring, and every jar was inseparable from people, but now in addition to feeding, other processes can be operated on the computer. Wu Rui, deputy general manager of production of Kampo Pharmaceutical, is excited about the benefits of digital transformation, "With the blessing of new technology, we plan to produce 43.75 million boxes of pharmaceuticals in 2024, an increase of 2708%。At present, 225 workshop workers are still sticking to their posts, sprinting to complete 9.24 million boxes of pharmaceuticals in the first quarter. After the holiday from February 8th to 16th, we will start to work intensively again. ”
In order to complete the "good start" in the first quarter with quality and quantity, the company has adjusted the structure, optimized the personnel, refined the positions and other measures, without increasing the labor cost, gave up the weekend rest time, organized the administrative staff to participate in the production of products through overtime, increased the daily output, and ensured the achievement of the set goals.
The efficiency and convenience brought by science and technology have liberated us from heavy manual labor, and at the same time, our production of proprietary Chinese medicines has truly realized the transformation from 'relying on experience' to 'relying on data'. Wu Rui said that in 2023, in addition to digital transformation, enterprises will also increase product competitiveness through successful marketing. At the same time, Hanfang Pharmaceutical also actively carries out "school-enterprise cooperation" with well-known universities inside and outside the province to select outstanding talents, which has added fresh blood to the interior.
In the new year, we are confident to exceed 600 million yuan in output value, and at the same time use products to 'speak' while strengthening the enterprise, and strive to bring good news to more patients. Wu Rui said.
Reporter Chen Jiayi.